SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040621
Filing Date
2023-08-09
Accepted
2023-08-09 16:17:45
Documents
45
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-20230630.htm   iXBRL 10-Q 1375904
2 EX-31.1 mnov-ex31_1.htm EX-31.1 17436
3 EX-31.2 mnov-ex31_2.htm EX-31.2 18031
4 EX-32.1 mnov-ex32_1.htm EX-32.1 12752
5 EX-32.2 mnov-ex32_2.htm EX-32.2 13295
  Complete submission text file 0000950170-23-040621.txt   4625195

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnov-20230630_pre.xml EX-101.PRE 185045
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnov-20230630_def.xml EX-101.DEF 81296
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnov-20230630_cal.xml EX-101.CAL 31474
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnov-20230630.xsd EX-101.SCH 27094
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnov-20230630_lab.xml EX-101.LAB 271655
39 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20230630_htm.xml XML 736590
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 231155426
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences